Johnson & Johnson (NYSE: JNJ) stock closed at 170.2 per share at the end of the most recent trading day (a -0.53% change compared to the prior day closing price) with a volume of 4.61M shares and market capitalization of 447.49B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 136400 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is -1.16%, while year-to-date (YTD) performance is -0.51%. JNJ stock has a five-year performance of 27.75%. Its 52-week range is between 155.72 and 186.69, which gives JNJ stock a 52-week price range ratio of 46.75%

Johnson & Johnson currently has a PE ratio of 24.00, a price-to-book (PB) ratio of 6.28, a price-to-sale (PS) ratio of 6.41, a price to cashflow ratio of 20.40, a PEG ratio of 2.32, a ROA of 11.18%, a ROC of 19.19% and a ROE of 27.93%. The company’s profit margin is 18.87%, its EBITDA margin is 30.10%, and its revenue ttm is $71.57 Billion , which makes it $27.20 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.57 for the next earnings report. Johnson & Johnson’s next earnings report date is -.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (2.06), with a target price of $186.33, which is +9.48% compared to the current price. The earnings rating for Johnson & Johnson stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.59% with a dividend per share of $4.52 and a payout ratio of 61.00%.

Johnson & Johnson has a Sell technical analysis rating based on Technical Indicators (ADX : 9.82, ATR14 : 2.70, CCI20 : -128.81, Chaikin Money Flow : -0.01, MACD : -1.03, Money Flow Index : 43.32, ROC : 0.23, RSI : 48.51, STOCH (14,3) : 19.31, STOCH RSI : 0.00, UO : 47.00, Williams %R : -80.69), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $30 325 274), Ashley McEvoy (Option Excercise at a value of $0), Jennifer L. Taubert (Option Excercise at a value of $0), Joaquin Duato (Option Excercise at a value of $11 037 462), Joseph J. Wolk (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $2 901 600), Kathryn E. Wengel (Sold 40 000 shares of value $6 920 039 ), Mathai Mammen (Option Excercise at a value of $0), Michael H. Ullmann (Option Excercise at a value of $0), Peter M. Fasolo (Option Excercise at a value of $0), Robert J. Decker (Option Excercise at a value of $1 339 234), Robert J. Decker (Sold 18 462 shares of value $3 216 740 ), Thibaut Mongon (Option Excercise at a value of $3 099 895), Thibaut Mongon (Sold 34 453 shares of value $6 072 408 ), Vanessa Broadhurst (Option Excercise at a value of $0), William Hait (Option Excercise at a value of $2 685 977), William Hait (Sold 29 599 shares of value $5 433 696 )